Cann Group Ltd Sustainability Reports
Cultivates medicinal cannabis and develops/manufactures GMP-certified medical cannabis products and active pharmaceutical ingredients, including ownership of Satipharm capsule technology.
Sector: Manufacturing
Country: Australia
Exchange: Australian Securities Exchange
LEI: 529900XX42XELLXVQE42
FIGI: BBG00GBRWZQ1
6 reports from 2015 to 2025
